Clinical Trials Browser

OTHER × Carcinoma × Sorafenib × Clear all

Carcinoma, Carcinoma, Renal Cell, Neoplasm Metastasis

NCT00576056 2017-02-15

Effectiveness and Safety Study of TACE Plus Oral Sorafenib for Unresectable HCC

Phase 2 Terminated

19 enrolled 7 charts

Gastrointestinal

Carcinoma, Carcinoma, Hepatocellular

NCT01556815 2012-04-25

Sorafenib Combined With Transarterial Chemoembolization in Treating HBV-infected Patients With Intermediate Hepatocellular Carcinoma

Phase 2 Unknown

40 enrolled

Gastrointestinal

Adenocarcinoma, Carcinoma, Digestive System Neoplasms, Carcinoma, Hepatocellular, Liver Diseases, Liver Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Glandular and Epithelial

Clinical Trials

MRI

Effectiveness and Safety Study of TACE Plus Oral Sorafenib for Unresectable HCC

Sorafenib Combined With Transarterial Chemoembolization in Treating HBV-infected Patients With Intermediate Hepatocellular Carcinoma